Cockle Shell-Derived Aragonite CaCO3 Nanoparticles for Co-Delivery of Doxorubicin and Thymoquinone Eliminates Cancer Stem Cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cockle Shell-Derived Aragonite CaCO3 Nanoparticles for Co-Delivery of Doxorubicin and Thymoquinone Eliminates Cancer Stem Cells
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 5, Pages 1900
Publisher
MDPI AG
Online
2020-03-10
DOI
10.3390/ijms21051900
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ultrastructural Changes and Antitumor Effects of Doxorubicin/Thymoquinone-Loaded CaCO3 Nanoparticles on Breast Cancer Cell Line
- (2019) Kehinde Muibat Ibiyeye et al. Frontiers in Oncology
- Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment
- (2018) Takanori Eguchi et al. PLoS One
- Evaluation of in vitro efficacy of docetaxel-loaded calcium carbonate aragonite nanoparticles (DTX-CaCO3NP) on 4T1 mouse breast cancer cell line
- (2017) Nahidah Ibrahim Hammadi et al. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
- Drug Resistance Driven by Cancer Stem Cells and Their Niche
- (2017) Marta Prieto-Vila et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- In vitro evaluation of a novel pH sensitive drug delivery system based cockle shell-derived aragonite nanoparticles against osteosarcoma
- (2017) Wenliang Fu et al. Journal of Experimental Nanoscience
- Dual nanoparticle drug delivery: the future of anticancer therapies?
- (2017) Michael R King et al. Nanomedicine
- A2B adenosine receptor agonist induces cell cycle arrest and apoptosis in breast cancer stem cells via ERK1/2 phosphorylation
- (2017) Seyyed Mehdi Jafari et al. CELLULAR ONCOLOGY
- Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
- (2017) Wenzhe Li et al. Scientific Reports
- The autophagy inhibitor chloroquine targets cancer stem cells in triple negative breast cancer by inducing mitochondrial damage and impairing DNA break repair
- (2016) Diana H. Liang et al. CANCER LETTERS
- CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel
- (2016) Eameema Muntimadugu et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Nanomedicine based curcumin and doxorubicin combination treatment of glioblastoma with scFv-targeted micelles: In vitro evaluation on 2D and 3D tumor models
- (2016) Can Sarisozen et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- MiRNA Transcriptome Profiling of Spheroid-Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell Line
- (2016) Lily Boo et al. International Journal of Biological Sciences
- Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells
- (2016) Lili He et al. Frontiers in Pharmacology
- Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases
- (2016) Yoshiya Horimoto et al. PLoS One
- Chitosan-Decorated Doxorubicin-Encapsulated Nanoparticle Targets and Eliminates Tumor Reinitiating Cancer Stem-like Cells
- (2015) Wei Rao et al. ACS Nano
- Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells
- (2015) Hai Wang et al. BIOMATERIALS
- Dual drug-loaded paclitaxel–thymoquinone nanoparticles for effective breast cancer therapy
- (2015) Parth Soni et al. JOURNAL OF NANOPARTICLE RESEARCH
- Principles of nanoparticle design for overcoming biological barriers to drug delivery
- (2015) Elvin Blanco et al. NATURE BIOTECHNOLOGY
- Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition
- (2015) Md. Asaduzzaman Khan et al. Oncotarget
- Multi-drug delivery system based on alginate/calcium carbonate hybrid nanoparticles for combination chemotherapy
- (2014) Jin-Long Wu et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- In VitroUltrastructural Changes of MCF-7 for Metastasise Bone Cancer and Induction of Apoptosis via Mitochondrial Cytochrome C Released by CaCO3/Dox Nanocrystals
- (2014) Abdullahi Shafiu Kamba et al. Biomed Research International
- Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds
- (2013) Tian-Meng Sun et al. BIOMATERIALS
- Thymoquinone suppresses metastasis of melanoma cells by inhibition of NLRP3 inflammasome
- (2013) Israr Ahmad et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Breast cancer stem cells
- (2013) Thomas W. Owens et al. Frontiers in Physiology
- Aldehyde dehydrogenases in cellular responses to oxidative/electrophilicstress
- (2012) Surendra Singh et al. FREE RADICAL BIOLOGY AND MEDICINE
- Reactive oxygen species and aldehyde dehydrogenase activity in Hodgkin lymphoma cells
- (2012) Jun-ichiro Ikeda et al. LABORATORY INVESTIGATION
- Anticancer Activities of Nigella sativa (Black Cumin)
- (2011) A Khan et al. African Journal of Traditional Complementary and Alternative Medicines
- Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells
- (2011) Alysha K. Croker et al. BREAST CANCER RESEARCH AND TREATMENT
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Thymoquinone reduces migration and invasion of human glioblastoma cells associated with FAK, MMP-2 and MMP-9 down-regulation
- (2011) Kaouther Kolli-Bouhafs et al. INVESTIGATIONAL NEW DRUGS
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
- (2010) Christophe Ginestier et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting Breast Cancer Stem Cells
- (2010) Suling Liu et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeting breast cancer stem cells
- (2010) Sean P. McDermott et al. Molecular Oncology
- Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of Metastasis
- (2010) Paola Marcato et al. STEM CELLS
- Breast cancer stem cells: tools and models to rely on
- (2009) Emmanuelle Charafe-Jauffret et al. BMC CANCER
- Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
- (2009) Emmanuelle Charafe-Jauffret et al. CANCER RESEARCH
- Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
- (2009) E. Charafe-Jauffret et al. CLINICAL CANCER RESEARCH
- High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability
- (2008) Alysha K. Croker et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search